Tricyclic antidepressants (TCAs) are an older class of medications that raise levels of serotonin and norepinephrine in the brain by preventing nerve cells from reabsorbing them. First introduced in the 1950s with imipramine, they were among the earliest drugs specifically developed to treat depression. While newer antidepressants have largely replaced them as first-line options, TCAs remain widely used for chronic pain, migraine prevention, and cases of depression that don’t respond to other treatments.
How TCAs Work in the Brain
TCAs affect at least five different neurotransmitter pathways, which explains both their effectiveness and their long list of side effects. The core action is straightforward: they block the reabsorption of serotonin and norepinephrine at nerve endings, leaving more of these chemical messengers available in the gap between neurons. Higher levels of both are linked to improved mood, reduced pain signaling, and better sleep regulation.
Different TCAs lean toward one neurotransmitter or the other. The “tertiary amines” in the group (like amitriptyline and imipramine) primarily boost serotonin, while the “secondary amines” (like nortriptyline and desipramine) have a stronger effect on norepinephrine. This distinction matters because it influences which drug a prescriber chooses for a given condition and what side effects to expect.
The problem is that TCAs don’t stop at serotonin and norepinephrine. They also block histamine receptors (causing drowsiness and weight gain), acetylcholine receptors (causing dry mouth, constipation, and blurred vision), and certain adrenaline receptors (causing dizziness from blood pressure drops). Newer antidepressants were designed specifically to avoid this scattershot receptor activity.
Available TCAs
Eight tricyclic antidepressants are currently available:
- Amitriptyline, the most commonly prescribed TCA, used heavily for pain and migraine prevention
- Nortriptyline, a secondary amine with somewhat fewer side effects than amitriptyline
- Imipramine, the original TCA, still used for depression and bedwetting in children
- Desipramine, a secondary amine that tends to be less sedating
- Doxepin, sometimes prescribed at very low doses for insomnia
- Trimipramine
- Protriptyline
- Amoxapine
What TCAs Are Used For
Depression was the original target, and TCAs still work well for it. But today, they’re prescribed just as often for conditions that have nothing to do with mood.
Chronic pain is one of the most common reasons people take a TCA. Amitriptyline and nortriptyline, at doses often lower than those used for depression, can reduce nerve pain, fibromyalgia symptoms, and other persistent pain conditions. The pain-relieving effect comes from boosting norepinephrine in spinal cord pathways that naturally dampen pain signals. A typical starting dose for nortriptyline is 25 mg, gradually increased as needed, with most people staying at or below 150 mg daily.
Migraine prevention is another well-established use. A meta-analysis of clinical trials found that TCAs significantly reduced migraine frequency compared to placebo, and the benefit grew over time. Patients treated for six months showed more improvement than those assessed at one month. Amitriptyline performed roughly as well as SSRIs and SNRIs for migraine prevention, though people taking TCAs were more likely to quit due to side effects.
How TCAs Compare to Newer Antidepressants
The assumption that SSRIs are more effective than TCAs turns out to be wrong. A large meta-analysis comparing the two classes found no difference in response rates when all enrolled patients were counted: 48% responded to SSRIs versus 48.6% to TCAs. Among people who completed treatment, TCAs actually came out ahead, with a 68.2% response rate compared to 63.2% for SSRIs. That difference was statistically significant.
So why did SSRIs overtake TCAs as the go-to prescription? Side effects and safety. In the same analysis, 22.4% of TCA users dropped out due to adverse reactions, compared to 15.9% on SSRIs. TCA users reported more drowsiness, dizziness, dry mouth, and constipation. SSRI users had more nausea and abdominal pain, but those symptoms were generally easier to tolerate. The bottom line: TCAs work at least as well for depression, but more people can stick with SSRIs long enough to benefit.
Common Side Effects
Most TCA side effects trace directly back to those extra receptors they block beyond serotonin and norepinephrine. Blocking acetylcholine receptors produces the “anticholinergic” cluster: dry mouth, constipation, urinary retention, blurred vision, and sometimes confusion or memory difficulties. Blocking histamine receptors causes sedation and weight gain. Blocking adrenaline receptors leads to lightheadedness when standing up, especially in the first few weeks.
Sedation can actually be useful. Many prescribers have patients take their dose at bedtime, turning a side effect into a sleep aid. This is particularly helpful for people dealing with both pain and insomnia. Over time, some side effects like drowsiness and dizziness tend to diminish as the body adjusts, while dry mouth and constipation often persist.
Serious Risks and Overdose Danger
The most important safety concern with TCAs is their narrow margin between a therapeutic dose and a dangerous one. An amount as low as 10 to 20 mg per kilogram of body weight can be life-threatening in overdose. For a 150-pound person, that could mean as few as 15 to 20 pills of a standard-dose prescription. Hospitalization rates for TCA overdose are significantly higher than for SSRI overdose.
The danger comes primarily from cardiac effects. In overdose, TCAs interfere with the electrical signals that coordinate the heartbeat, causing the heart to beat irregularly, too slowly, or to stop entirely. They also cause dangerous drops in blood pressure, seizures, and loss of consciousness. This toxicity profile is the main reason TCAs are prescribed cautiously for anyone with a history of suicidal thoughts or heart conditions.
At normal prescribed doses, cardiac effects are much milder, but TCAs can still slightly alter heart rhythm. People with pre-existing heart conditions typically need monitoring, and an electrocardiogram is sometimes checked before starting treatment.
TCAs in Older Adults
The American Geriatrics Society’s Beers Criteria, a widely used guide for safe prescribing in people over 65, recommends avoiding most TCAs in older adults. The reasons stack up quickly. Anticholinergic effects that are merely annoying in younger people become genuinely dangerous in older adults: confusion can mimic or worsen dementia, urinary retention becomes more problematic, and constipation can progress to bowel obstruction.
Falls are a particular concern. TCAs can cause unsteadiness, impaired coordination, fainting from blood pressure drops, and excessive sedation, all of which increase fracture risk in a population already vulnerable to falls. Tertiary TCAs like amitriptyline and imipramine carry the highest risk because of their stronger anticholinergic and blood-pressure-lowering effects. TCAs can also disrupt sodium balance in older adults, occasionally causing a condition where sodium levels drop low enough to cause confusion, nausea, or seizures. For these reasons, when an older adult does need a TCA, secondary amines like nortriptyline or desipramine are generally preferred for their somewhat milder side effect profile.